Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2012
11/28/2012CN102802661A Engineered Fc Regions For Site-specific Conjugation
11/28/2012CN102802660A Immunogenic compositions having low sodium chloride concentration
11/28/2012CN102802654A Vaccine therapy for choroidal neovascularization
11/28/2012CN102796763A Preparation method and application of carp spermary bioreactor
11/28/2012CN102796757A Carrier capable of showing and expressing helicobacter pylori protein on surface of lactococcus lactis, and preparation method and application of carrier
11/28/2012CN102796755A Lactococcus lactis expression vector and preparation method and application thereof
11/28/2012CN102796749A Epidemic encephalitis B/dengue chimeric virus with epidemic encephalitis B virus attenuated strain as gene framework and application of epidemic encephalitis B/dengue chimeric virus
11/28/2012CN102796710A Non-pathogenic recombinant attenuated rabies virus strain and construction method and application thereof
11/28/2012CN102796709A Liver cancer-specific gene-virus and application thereof
11/28/2012CN102796705A Dac hyp compositions and methods
11/28/2012CN102796200A Hybrid peptide bursin adjuvant and preparation method and application thereof
11/28/2012CN102796172A Hepatitis B virus (HBV) specific human leukocyte antigen-A33 (HLA-A33) restrictive epitope peptides and application thereof
11/28/2012CN102796144A Thomsen-Friedenreich (TF) antigen and TF antigen analogue and their chemoenzymatic synthesis method and use
11/28/2012CN102793927A Swine fever vaccine heat-resistant freeze-drying protective agent, and preparation method and application thereof
11/28/2012CN102793923A Duck tembusu virus (DTMUV) disease immunotherapy preparation and preparation method thereof
11/28/2012CN102793922A Method for treating neoplastic disease in body of mammals
11/28/2012CN102793921A Methods for treating tweak-related conditions
11/28/2012CN102793920A Compound immunopotentiator, inactivated vaccine for poultry, and preparation method thereof
11/28/2012CN102793919A Pharmaceutical composition and method for producing the same
11/28/2012CN102793918A Duck flavivirus subunit vaccine, as well as a preparation method and application thereof
11/28/2012CN102793917A Porcine encephalitis B vaccine and preparation method thereof
11/28/2012CN102793916A Vibrio anguillarum attenuated vaccine and its application
11/28/2012CN102793915A Production method of acellular pertussis vaccine
11/28/2012CN102793914A Novel vascular endothelial cell vaccine and preparation method thereof
11/28/2012CN102793913A Tumor vaccine of recombinant murine EPS8 gene, and preparation method and application thereof
11/28/2012CN102793912A Dendritic cell (DC) tumor vaccine and preparation method thereof
11/28/2012CN102319441B Preparation method of PLGA swine influenza DNA vaccine microsphere
11/28/2012CN102258500B Oral slow release influenza vaccine and preparation method thereof
11/28/2012CN102154324B Construction method of mycobacterium tuberculosis fusion protein Mtb 10.4-Hsp16.3, expression method thereof, purification method thereof and application thereof
11/28/2012CN102153644B Antigenic peptide for dimerization of epidermal growth factor receptor
11/28/2012CN102002048B Water-soluble anionic bacteriochlorophyll derivatives and their uses
11/28/2012CN101978971B Method for establishing enterovirus71 intramuscular injection-infected suckling mouse model
11/28/2012CN101954079B Vaccine adjuvant of swine mycoplasmal pneumonia live vaccine, and preparation method and application thereof
11/28/2012CN101954078B Vaccine adjuvant for swine enzootic pneumonia vaccine and preparation method and application thereof
11/28/2012CN101918549B Improved humanized anti-human alpha9-integrin antibody
11/28/2012CN101613402B Surface protein of streptococcus suis 2-type and preparation method and application thereof
11/28/2012CN101613400B Surface cytoderm protein of streptococcus suis 2-type and preparation method and application thereof
11/28/2012CN101613399B Surface protein of streptococcus suis type-2, preparation method thereof and application
11/28/2012CN101524537B Influenza oral tablet vaccine, influenza oral slow-release vaccine and preparation methods thereof
11/28/2012CN101199843B Whooping cough genetic engineering blending second unit vaccine and preparing method thereof
11/28/2012CN101123984B Implantable device
11/27/2012US8321143 Synthetic active peptide fragments
11/27/2012US8318912 Targeted immune conjugate comprising an antibody to glycophorin A and a M2e peptide
11/27/2012US8318911 Anti-EpCAM antibody and uses thereof
11/27/2012US8318910 IL-13 receptor antibodies
11/27/2012US8318908 Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof
11/27/2012US8318907 Fc variants with altered binding to FcRn
11/27/2012US8318906 EMP2 antibodies and their therapeutic uses
11/27/2012US8318905 Antibodies for depletion of ICOS-positive cells in vivo
11/27/2012US8318901 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
11/27/2012US8318897 Nucleotide and amino acid sequences encoding an exported protein 1 derived from Plasmodium vivax and uses thereof
11/27/2012US8318791 Substituted imidazole derivatives
11/27/2012US8318687 Recombinant adeno-associated virus vector for treatment of Alzheimer disease
11/27/2012US8318480 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
11/27/2012US8318425 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/27/2012US8318421 Hepatitis-C virus testing
11/27/2012US8318419 Antiviral screening method to identify inhibitors of phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] binding to the HIV gag matrix (MA) protein
11/27/2012US8318185 Recombinant malaria vaccine
11/27/2012US8318184 MGLU2 agonists
11/27/2012US8318183 Plasmodium liver stage antigens
11/27/2012US8318182 Vault compositions for immunization against Chlamydia genital infection
11/27/2012US8318181 Botulinum nanoemulsions
11/27/2012US8318180 Protective vaccine against Staphylococcus aureus biofilms comprising cell wall-associated immunogens
11/27/2012US8318179 Neisserial vaccines
11/27/2012US8318177 Viral chemokine-antigen fusion proteins
11/27/2012US8318175 Method for treating amyloid disease
11/27/2012US8318174 Survivin-derived peptides and use thereof
11/27/2012US8318173 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits
11/27/2012US8318172 Breaking immunological tolerance with a genetically encoded unnatural amino acid
11/27/2012US8318171 Neurotoxic oligomers
11/27/2012US8318170 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/27/2012US8318169 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
11/27/2012US8318168 Antigenic GM-CSF peptides and antibodies to GM-CSF
11/27/2012US8318167 Methods and compositions for regulating iron homeostasis by modulation of BMP-6
11/27/2012US8318166 Ligands of HVEM for treating hematologic malignancies
11/27/2012US8318165 Antibodies against human melanoma-associated chondroitin sulphate proteoglycan (MCSP)
11/27/2012US8318164 Anti A beta antibody formulation
11/27/2012US8318163 Anti-pan neuropilin antibody and binding fragments thereof
11/27/2012US8318162 Antibodies to high molecular weight melanoma associated antigen
11/27/2012US8318161 Anti-oxidized LDL antibody formulation
11/27/2012US8318160 Treatment of cancer with novel anti-IL13 monoclonal antibodies
11/27/2012US8318159 Anti-IGF antibodies
11/27/2012US8318153 Method of medically treating an individual
11/27/2012US8318148 Attenuated bacteria useful in vaccines
11/27/2012CA2672902C Formulations
11/27/2012CA2658221C Anti-cd40 monoclonal antibody
11/27/2012CA2634169C Method for treating disseminated cancer
11/27/2012CA2611778C Compositions and methods for the diagnosis and treatment of tumor
11/27/2012CA2527640C Tumor antigens for prevention and/or treatment of cancer
11/27/2012CA2488404C Genes and polypeptides relating to human colon cancers
11/27/2012CA2461579C Porcine adenovirus e1 region
11/27/2012CA2452836C Meningococcus adhesins nada, app and orf 40
11/27/2012CA2432525C Streptococcus pyogenes antigens and corresponding dna fragments
11/27/2012CA2325605C Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein said peptides bind to mhc class i and mhc class ii molecules, and uses thereof
11/27/2012CA2181832C Immunization by inoculation of dna transcription unit
11/22/2012WO2012159100A1 Il-12 p40 monomer, monoclonal antibody against p40 homodimer and the combination of the two for autoimmune disease treatment
11/22/2012WO2012158978A1 Thermostable vaccine compositions and methods of preparing same
11/22/2012WO2012158948A1 Human immunodeficiency virus neutralizing antibodies adn methods of use thereof
11/22/2012WO2012158945A2 Compositions and methods for treating charcot-marie-tooth diseases and related neuronal diseases
11/22/2012WO2012158704A1 Fgfr1 agonists and methods of use
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 1823